AU666838B2 - Compounds and compositions which inhibit bone resorption - Google Patents

Compounds and compositions which inhibit bone resorption

Info

Publication number
AU666838B2
AU666838B2 AU90632/91A AU9063291A AU666838B2 AU 666838 B2 AU666838 B2 AU 666838B2 AU 90632/91 A AU90632/91 A AU 90632/91A AU 9063291 A AU9063291 A AU 9063291A AU 666838 B2 AU666838 B2 AU 666838B2
Authority
AU
Australia
Prior art keywords
pthrp
leu
ser
bone resorption
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU90632/91A
Other languages
English (en)
Other versions
AU9063291A (en
Inventor
Anna Jane Fenton
R. Glenn Hammonds
Bruce E Kemp
Thomas J. Martin
Geoffrey Charles Nicholson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Genentech Inc
Original Assignee
University of Melbourne
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, Genentech Inc filed Critical University of Melbourne
Priority to AU90632/91A priority Critical patent/AU666838B2/en
Publication of AU9063291A publication Critical patent/AU9063291A/en
Application granted granted Critical
Publication of AU666838B2 publication Critical patent/AU666838B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
AU90632/91A 1990-12-13 1991-12-13 Compounds and compositions which inhibit bone resorption Expired AU666838B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU90632/91A AU666838B2 (en) 1990-12-13 1991-12-13 Compounds and compositions which inhibit bone resorption

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPK387990 1990-12-13
AUPK3879 1990-12-13
AUPK956791 1991-11-19
AUPK9567 1991-11-19
PCT/AU1991/000580 WO1992010511A1 (en) 1990-12-13 1991-12-13 Compounds and compositions which inhibit bone resorption
AU90632/91A AU666838B2 (en) 1990-12-13 1991-12-13 Compounds and compositions which inhibit bone resorption

Publications (2)

Publication Number Publication Date
AU9063291A AU9063291A (en) 1992-07-08
AU666838B2 true AU666838B2 (en) 1996-02-29

Family

ID=25643990

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90632/91A Expired AU666838B2 (en) 1990-12-13 1991-12-13 Compounds and compositions which inhibit bone resorption

Country Status (12)

Country Link
US (1) US5688760A (cg-RX-API-DMAC10.html)
EP (1) EP0561877B1 (cg-RX-API-DMAC10.html)
JP (1) JP3280021B2 (cg-RX-API-DMAC10.html)
AT (1) ATE181336T1 (cg-RX-API-DMAC10.html)
AU (1) AU666838B2 (cg-RX-API-DMAC10.html)
CA (1) CA2096933C (cg-RX-API-DMAC10.html)
DE (1) DE69131355T2 (cg-RX-API-DMAC10.html)
DK (1) DK0561877T3 (cg-RX-API-DMAC10.html)
ES (1) ES2135398T3 (cg-RX-API-DMAC10.html)
GR (1) GR3030947T3 (cg-RX-API-DMAC10.html)
HU (1) HUT64565A (cg-RX-API-DMAC10.html)
WO (1) WO1992010511A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2158762A1 (en) * 1993-04-08 1994-10-27 Hans Rink Cyclic compounds and compositions which inhibit bone resorption
GB9425582D0 (en) * 1994-12-19 1995-02-15 Iaf Biochem Int Peptides having immunomodulatory activity
EP0811383B1 (en) * 1995-02-20 2007-05-30 Yukio Kato Remedies for arthrosis deformans and inflammatory joint diseases
NZ304308A (en) * 1995-03-20 1998-02-26 Shell Int Research Regeneration of catalyst particles contaminated with carbonaceous and/or sulphur containing materials
EP0902036A1 (en) 1997-09-05 1999-03-17 Roche Diagnostics GmbH Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
NZ506839A (en) * 1998-03-09 2003-05-30 Zealand Pharma As Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
CA2472472A1 (en) * 2002-01-10 2003-07-24 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
WO2004016151A2 (en) * 2002-08-15 2004-02-26 Osteotrophin, Llc Pthrp-derived modulators of smooth muscle proliferation
WO2009033786A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
ES2605813B1 (es) * 2015-09-16 2018-01-17 Fundación Instituto De Investigación Sanitaria Fundación Jiménez Díaz Uso de osteostatina en la preparación de un medicamento para el tratamiento de artrosis
WO2018215831A2 (en) * 2017-05-22 2018-11-29 National Hellenic Research Foundation Macrocyclic modulators of disease associated protein misfolding and aggregation
WO2024238631A2 (en) * 2023-05-15 2024-11-21 Purdue Research Foundation A cytokine-like propeptide gene therapy platform

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606972B2 (en) * 1987-05-20 1991-02-21 Genentech Inc. Method and compositions for making acsf and acsf antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
JPS63259972A (ja) * 1987-04-17 1988-10-27 Fuji Electric Co Ltd 燃料電池設備
US5312810A (en) * 1987-05-20 1994-05-17 The University Of Melbourne Method and compositions for making ACSF and ACSF antagonists
US4819504A (en) * 1987-05-27 1989-04-11 Sampson Sports, Inc. Self contained braking system for bicycle pedals
EP0341962B1 (en) * 1988-05-09 1995-03-15 Merck & Co. Inc. Humoral hypercalcemic factor antagonists
JP2752987B2 (ja) * 1988-06-01 1998-05-18 株式会社東芝 リン酸型燃料電池発電プラント

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606972B2 (en) * 1987-05-20 1991-02-21 Genentech Inc. Method and compositions for making acsf and acsf antagonists

Also Published As

Publication number Publication date
DK0561877T3 (da) 1999-12-27
JPH06503330A (ja) 1994-04-14
ES2135398T3 (es) 1999-11-01
CA2096933C (en) 2003-05-13
ATE181336T1 (de) 1999-07-15
EP0561877B1 (en) 1999-06-16
DE69131355D1 (de) 1999-07-22
EP0561877A1 (en) 1993-09-29
AU9063291A (en) 1992-07-08
HU9301726D0 (en) 1993-10-28
GR3030947T3 (en) 1999-11-30
HUT64565A (en) 1994-01-28
JP3280021B2 (ja) 2002-04-30
WO1992010511A1 (en) 1992-06-25
DE69131355T2 (de) 1999-12-30
US5688760A (en) 1997-11-18
CA2096933A1 (en) 1992-06-14
EP0561877A4 (cg-RX-API-DMAC10.html) 1994-03-23

Similar Documents

Publication Publication Date Title
CN101693736B (zh) 新的肽
JP4026854B2 (ja) 腸栄養性ｇｌｐ―２ペプチドのアンタゴニスト
EP3192520A1 (en) Therapeutic agents for reducing parathyroid hormone levels
US7351792B2 (en) Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
AU666838B2 (en) Compounds and compositions which inhibit bone resorption
US5717062A (en) Cyclic analogs of PTH and PTHrP
JPH04506664A (ja) 治療用ペプチド
CA2403447A1 (en) Peptide derivative
SK287397B6 (sk) Analógy paratyroidného hormónu na liečenie osteoporózy
SK282267B6 (sk) Bombezínu antagonistický peptid, farmaceutický prostriedok s jeho obsahom a jeho použitie
JP2002502381A (ja) 環状ｃｒｆアンタゴニストペプチド
AU701677B2 (en) Recombinant C140 receptor and its agonists and antagonists
TW469273B (en) Bone stimulating factor
US8980843B2 (en) Leptin agonist and methods of use
US6352973B1 (en) Bone stimulating factor
KR19980701637A (ko) 재조합 ｃ１４０ 리셉터, 그것의 아고니스트 및 길항제, 그리고 리셉터를 코드화하는 핵산
US10494405B2 (en) Methods and compositions for the treatment of arthritis
Batra et al. Pneumadin: a new lung peptide which triggers antidiuresis
CA2252369A1 (en) Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
CA2355254A1 (en) Use of peptide
US20030027753A1 (en) Bone stimulating factor
HK1241270A1 (en) Therapeutic agents for reducing parathyroid hormone levels
HK1149275A (en) Analogs of parathyroid hormone
HK1096976B (en) Analogs of parathyroid hormone
MXPA97007949A (en) Peptido-2 similar to glucagon and its use terapeut